We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves Start of Phase I/II Clinical Trial in the US

News   May 05, 2015

 
FDA Approves Start of Phase I/II Clinical Trial in the US
 
 
Advertisement
 

RELATED ARTICLES

NIH Closes Enrolment for Two Sub-Studies in ACTIV-3 Trial

News

The ACTIV-3 clinical trial, which is evaluating the safety and efficacy of investigational therapeutics for COVID-19 in hospitalized patients, has closed enrolment in two sub-studies. The first sub-study was examining the investigational monoclonal antibody therapy VIR-7831 and the second was evaluating a combined monoclonal antibody therapy containing BRII-196 and BRII-198.

READ MORE

Induced Pluripotent Stem Cells Reveal Causes of Disease

News

Scientists from the German Cancer Research Center and the European Molecular Biology Laboratory have studied genotype-phenotype relationships in iPSCs using data from approximately one thousand donors.

READ MORE

Nanoparticle-Infused Contact Lenses Correct Color Blindness

News

Dyed contact lenses currently in development for color blindness are potentially harmful and unstable. Now, researchers have infused contact lenses with gold nanoparticles to create a safer way to see colors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE